Biogen

Biogen is a prominent global biotechnology company founded in 1978, renowned for pioneering innovative treatments aimed at transforming the lives of patients dealing with complex diseases. With a strong focus on areas such as neurology, neuropsychiatry, and rare diseases, Biogen advances a diverse pipeline of potential therapies, including groundbreaking solutions for Alzheimer's disease, multiple sclerosis, and spinal muscular atrophy.

Dedicated to its mission of serving humanity through science, Biogen prioritizes health equity and environmental responsibility, ensuring that its products are accessible and beneficial to all. The company emphasizes inclusivity in its clinical trials, actively recruiting underrepresented patients to enhance the diversity of its research.

Biogen’s commitment to excellence is reflected in its robust research and development capabilities, which facilitate the manufacture of high-quality medicines. By striving for long-term growth and fostering a corporate culture centered on ethics and patient focus, Biogen continues to be a leader in the biotechnology sector, making a significant impact on global health.